Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Assets (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Other Non-Current Assets for 7 consecutive years, with $19000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 58.33% to $19000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19000.0 through Dec 2025, up 58.33% year-over-year, with the annual reading at $19000.0 for FY2025, 58.33% up from the prior year.
  • Other Non-Current Assets hit $19000.0 in Q4 2025 for Eton Pharmaceuticals, roughly flat from $19000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $36000.0 in Q1 2021 to a low of $12000.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $15900.0 across 5 years, with a median of $12000.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: crashed 71.6% in 2021 and later surged 58.33% in 2025.
  • Year by year, Other Non-Current Assets stood at $21000.0 in 2021, then plummeted by 42.86% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then soared by 58.33% to $19000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for ETON at $19000.0 in Q4 2025, $19000.0 in Q3 2025, and $12000.0 in Q2 2025.